
Natco Pharma Ltd. (INR)829.33.2 (0.4%)
Exchange ScripsBSE524816NSENATCOPHARMISININE987B01026
Indicators | Value | Signal |
---|---|---|
5-DMA | 817.6 | Bullish |
10-DMA | 807.73 | Bullish |
20-DMA | 806.11 | Bullish |
50-DMA | 1026.23 | Bearish |
100-DMA | 1211.6 | Bearish |
200-DMA | 1285.24 | Bearish |
Field | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 | Dec-2023 |
---|---|---|---|---|---|
Promoters | 21 | 21 | 21 | 21 | 21 |
Foreign Investors | --- | --- | --- | --- | --- |
Domestic Investors | 21 | 21 | 21 | 21 | 21 |
Public Investors | 345311 | 302923 | 251464 | 228446 | 207550 |
Government | --- | --- | 1 | --- | --- |
Below figures are in Rs. Crores
Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Other Income | 1281 | 1285 | 990 | 1060 |
Operating Profit | 18795 | 10402 | 3625 | 7098 |
Interest | 192 | 145 | 177 | 133 |
Depreciation | 1868 | 1638 | 1426 | 1169 |
Profit Before Tax | 16735 | 8619 | 2022 | 5796 |
Consolidated Net Profit | 13883 | 7153 | 1700 | 4409 |
Adjusted EPS | 78 | 39 | 9 | 24 |
Below figures are in Rs. Crores
Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Share Capital | 358 | 365 | 365 | 365 |
Total Reserves | 58173 | 48373 | 42237 | 40676 |
Minority Interest | --- | --- | --- | 18 |
Total Non-Current Liabilities | 610 | 1005 | 1351 | 1429 |
Total Liabilities | 68869 | 56574 | 51091 | 47919 |
Capital Work in Progress | 1373 | 643 | 1295 | 2234 |
Total Assets | 68869 | 56574 | 51091 | 47919 |
Below figures are in Rs. Crores
Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Cash Flow from Operating Activities | 12116 | 8491 | 465 | 2988 |
Cash Flow from Investing Activities | -10327 | -4771 | -53 | -1033 |
Cash Flow from Financing Activitie | -2469 | -3630 | 348 | -1857 |
Net Cash Inflow / Outflow | -680 | 90 | 760 | 98 |
Natco Pharma Ltd.
829.33.2 (0.4%)
Announcing Stock of the Month!